Catalent, Inc. to Present at the SVB Leerink 10th Annual Global Healthcare Conference
2021年2月20日 - 6:15AM
ビジネスワイヤ(英語)
Catalent, Inc. (NYSE: CTLT), the leading global provider of
advanced delivery technologies, development, and manufacturing
solutions for drugs, biologics, cell and gene therapies, and
consumer health products, today announced that members of its
executive leadership team will virtually present at the SVB Leerink
10th Annual Global Healthcare Conference at 11:20 a.m. ET on
February 25, 2021.
A live webcast of the presentation will be accessible at
http://investor.catalent.com and will be available for replay
following the event.
About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT), an S&P 500® Company, is the
leading global provider of advanced delivery technologies,
development, and manufacturing solutions for drugs, biologics, cell
and gene therapies, and consumer health products. With over 85
years serving the industry, Catalent has proven expertise in
bringing more customer products to market faster, enhancing product
performance and ensuring reliable global clinical and commercial
product supply. Catalent employs over 14,000 people, including over
2,400 scientists and technicians, at more than 40 facilities across
four continents, and in fiscal year 2020 generated over $3 billion
in annual revenue. Catalent is headquartered in Somerset, New
Jersey. For more information, visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210219005442/en/
Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com
Catalent (NYSE:CTLT)
過去 株価チャート
から 6 2024 まで 7 2024
Catalent (NYSE:CTLT)
過去 株価チャート
から 7 2023 まで 7 2024